Latest Insider Transactions at Pulmonx Corp (LUNG)
This section provides a real-time view of insider transactions for Pulmonx Corp (LUNG). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Pulmonx Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Pulmonx Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 15
2021
|
Geoffrey Beran Rose CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,000
-4.2%
|
$266,000
$38.12 P/Share
|
|
Sep 01
2021
|
Alissa Hsu Lynch Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,610
+50.0%
|
-
|
|
Sep 01
2021
|
Tiffany Sullivan |
BUY
Grant, award, or other acquisition
|
Direct |
4,610
+50.0%
|
-
|
|
Sep 01
2021
|
Glendon E. French Iii |
SELL
Open market or private sale
|
Direct |
1,421
-0.12%
|
$56,840
$40.09 P/Share
|
|
Sep 01
2021
|
David Aaron Lehman GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
383
-2.18%
|
$15,320
$40.09 P/Share
|
|
Sep 01
2021
|
Geoffrey Beran Rose CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
355
-0.21%
|
$14,200
$40.09 P/Share
|
|
Sep 01
2021
|
Derrick Sung Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
383
-0.16%
|
$15,320
$40.09 P/Share
|
|
Aug 19
2021
|
Glendon E. French Iii |
SELL
Open market or private sale
|
Direct |
25,000
-2.07%
|
$900,000
$36.63 P/Share
|
|
Aug 19
2021
|
Glendon E. French Iii |
SELL
Open market or private sale
|
Indirect |
1,000
-4.07%
|
$36,000
$36.59 P/Share
|
|
Aug 16
2021
|
Geoffrey Beran Rose CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,000
-4.03%
|
$252,000
$36.71 P/Share
|
|
Jul 15
2021
|
Glendon E. French Iii |
SELL
Open market or private sale
|
Indirect |
1,000
-1.31%
|
$38,000
$38.21 P/Share
|
|
Jul 15
2021
|
Glendon E. French Iii |
SELL
Open market or private sale
|
Direct |
25,000
-0.68%
|
$950,000
$38.4 P/Share
|
|
Jul 15
2021
|
Glendon E. French Iii |
BUY
Exercise of conversion of derivative security
|
Direct |
4,375
+0.35%
|
$8,750
$2.2 P/Share
|
|
Jul 15
2021
|
Geoffrey Beran Rose CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,000
-1.3%
|
$266,000
$38.56 P/Share
|
|
Jul 13
2021
|
Boston Scientific Corp > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
2,500,000
-62.69%
|
$92,500,000
$37.45 P/Share
|
|
Jul 12
2021
|
Daniel P Florin |
BUY
Open market or private purchase
|
Direct |
2,500
+24.92%
|
$100,000
$40.0 P/Share
|
|
Jun 25
2021
|
Daniel P Florin |
BUY
Open market or private purchase
|
Direct |
2,222
+30.63%
|
$97,768
$44.12 P/Share
|
|
Jun 17
2021
|
Glendon E. French Iii |
SELL
Open market or private sale
|
Indirect |
1,000
-3.76%
|
$42,000
$42.68 P/Share
|
|
Jun 17
2021
|
Glendon E. French Iii |
SELL
Open market or private sale
|
Direct |
25,000
-1.0%
|
$1,075,000
$43.15 P/Share
|
|
Jun 17
2021
|
Glendon E. French Iii |
BUY
Exercise of conversion of derivative security
|
Direct |
4,375
+0.35%
|
$8,750
$2.2 P/Share
|
|
Jun 01
2021
|
Thomas William Burns |
BUY
Grant, award, or other acquisition
|
Direct |
2,810
+50.0%
|
-
|
|
Jun 01
2021
|
Richard Ferrari |
BUY
Grant, award, or other acquisition
|
Direct |
2,810
+12.89%
|
-
|
|
Jun 01
2021
|
Daniel P Florin |
BUY
Grant, award, or other acquisition
|
Direct |
2,810
+50.0%
|
-
|
|
Jun 01
2021
|
Glendon E. French Iii |
BUY
Grant, award, or other acquisition
|
Direct |
45,600
+3.53%
|
-
|
|
Jun 01
2021
|
David Aaron Lehman GENERAL COUNSEL |
BUY
Grant, award, or other acquisition
|
Direct |
17,600
+50.0%
|
-
|
|
Jun 01
2021
|
Dana G Mead Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
2,810
+8.8%
|
-
|
|
Jun 01
2021
|
Georgia Melenikiotou |
BUY
Grant, award, or other acquisition
|
Direct |
2,810
+50.0%
|
-
|
|
Jun 01
2021
|
Geoffrey Beran Rose CHIEF COMMERCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
17,600
+8.87%
|
-
|
|
Jun 01
2021
|
Derrick Sung Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,600
+6.88%
|
-
|
|
May 24
2021
|
Geoffrey Beran Rose CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,797
-0.72%
|
$196,677
$41.34 P/Share
|
|
May 20
2021
|
Glendon E. French Iii |
SELL
Open market or private sale
|
Indirect |
1,000
-3.63%
|
$40,000
$40.75 P/Share
|
|
May 20
2021
|
Glendon E. French Iii |
SELL
Open market or private sale
|
Direct |
25,000
-1.02%
|
$1,025,000
$41.6 P/Share
|
|
May 18
2021
|
Geoffrey Beran Rose CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
49,428
+22.93%
|
$49,428
$1.4 P/Share
|
|
May 10
2021
|
Geoffrey Beran Rose CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,797
-0.99%
|
$196,677
$41.68 P/Share
|
|
Apr 19
2021
|
Geoffrey Beran Rose CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,797
-3.8%
|
$206,271
$43.24 P/Share
|
|
Apr 15
2021
|
Glendon E. French Iii |
SELL
Open market or private sale
|
Indirect |
1,000
-3.5%
|
$43,000
$43.7 P/Share
|
|
Apr 15
2021
|
Glendon E. French Iii |
SELL
Open market or private sale
|
Direct |
25,000
-1.0%
|
$1,075,000
$43.92 P/Share
|
|
Apr 06
2021
|
Boston Scientific Corp > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
650,000
-14.01%
|
$27,950,000
$43.6 P/Share
|
|
Apr 06
2021
|
Derrick Sung Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-0.75%
|
$235,000
$47.54 P/Share
|
|
Apr 05
2021
|
Derrick Sung Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-1.09%
|
$240,000
$48.06 P/Share
|
|
Apr 05
2021
|
Geoffrey Beran Rose CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,797
-2.11%
|
$230,256
$48.03 P/Share
|
|
Mar 30
2021
|
Boston Scientific Corp > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,350,000
-22.54%
|
$54,000,000
$40.8 P/Share
|
|
Oct 05
2020
|
Staffan Lindstrand Director |
BUY
Conversion of derivative security
|
Indirect |
1,133,728
+23.5%
|
-
|
|
Oct 05
2020
|
Dana G Mead Jr. |
BUY
Open market or private purchase
|
Direct |
26,315
+50.0%
|
$499,985
$19.0 P/Share
|
|
Oct 05
2020
|
Dana G Mead Jr. |
BUY
Conversion of derivative security
|
Indirect |
1,524,109
+21.97%
|
-
|
|
Oct 05
2020
|
Georgia Melenikiotou |
BUY
Open market or private purchase
|
Direct |
26,315
+50.0%
|
$499,985
$19.0 P/Share
|
|
Oct 05
2020
|
Richard Ferrari |
BUY
Open market or private purchase
|
Direct |
13,157
+44.84%
|
$249,983
$19.0 P/Share
|
|
Oct 05
2020
|
Richard Ferrari |
BUY
Conversion of derivative security
|
Direct |
3,030
+50.0%
|
-
|
|
Oct 05
2020
|
Richard Ferrari |
BUY
Conversion of derivative security
|
Indirect |
1,221,489
+25.79%
|
-
|
|
Oct 05
2020
|
Daniel P Florin |
BUY
Open market or private purchase
|
Indirect |
15,789
+50.0%
|
$299,991
$19.0 P/Share
|